DANVERS, Mass.--(BUSINESS WIRE)--Abiomed (NASDAQ: ABMD), maker of the Impella heart pump, has acquired Breethe, developer of a novel extracorporeal membrane oxygenation (ECMO) system that will ...
J&J’s Abiomed and manufacturing partner Oscor warned of a bleeding risk from devices used to introduce catheters to the body.
GlobalData on MSN
Abiomed’s Impella heart pump introducer kits linked to leakage issue in FDA alert
Abiomed has reported eight instances of major bleeding, with three ‘contested’ patient deaths related to a leakage issue with its Impella introducer kits.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results